Scinai
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jerusalem Biopark Hadassah Ein Kerem Cam...Phone Number
+972 89302529Website
www.scinai.comRevenue
<$5 MillionStock Symbol
SCNIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Scinai
Scinai Immunotherapeutics Ltd (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.Explore more
Scinai Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scinai your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Scinai recently announced quarterly report
Funding: Get notified immidiatlly once Scinai has new funding data
Product Launch: Get notified when Scinai launches new products
Scinai, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Scinai has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Scinai
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Scinai had a recent Job posting/layoffs
Check out if Scinai is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Scinai is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Scinai is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Scinai.
Scinai financials insights
Gather financial insights about Scinai, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$2.6M
Scinai Tech Stack
A closer look at the technologies used by Scinai
Most Recent Scoops
Funding
Funding
Earnings
Earnings, Finance
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Earnings
Earnings, Finance
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Scinai News & Media
Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility
JERUSALEM, May 20, 2026 /PRNewswire/ – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics, today announced that its wholly owned subsidiary, Scinai Biopharma...Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe
JERUSALEM, May 15, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company focused on inflammation and immunology, today announced that members of its leadership team will lead a strategic roundtable discussion at the 7th...Institutional Capital Returns as This Microcap Biotech Locks In Fresh Funding
Real-time index price for TSX Comp Carbon Price Risk 2030 Adj Index (XECP), along with buy or sell indicators, analysis, charts, historical performance, news and moreScinai Immunotherapeutics Announces $2.61 Million Private Placement Financing
Financing led by institutional life sciences investor, with participation from new and existing investors Capital expected to support expansion of CDMO platform and advancement of customer programs JERUSALEM, April 24, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI),...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scinai
Sign Up For FreeTo access detailed company insights
Scinai Immunotherapeutics Ltd (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manuf... Read More
